Menu
← Oncology Approval Tracker
FDA DECISION ·
Xeloda + combination chemotherapy
capecitabine with combination chemotherapy · Genentech
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Adjuvant use as a component of combination chemotherapy in adults with pancreatic adenocarcinoma.
LAMPGEN ANALYSIS
Why it matters
The decision formalizes an adjuvant pancreatic cancer use for an established oral therapy.
What research teams should watch
Link the resection and pathology records to adjuvant treatment dates and monitor oral adherence.
PRIMARY RECORDS